Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas.
Piha-Paul SA, Geva R, Tan TJ, Lim DW, Hierro C, Doi T, Rahma O, Lesokhin A, Luke JJ, Otero J, Nardi L, Singh A, Xyrafas A, Chen X, Mataraza J, Bedard PL. Piha-Paul SA, et al. Among authors: doi t. J Immunother Cancer. 2021 Aug;9(8):e002863. doi: 10.1136/jitc-2021-002863. J Immunother Cancer. 2021. PMID: 34389618 Free PMC article. Clinical Trial.
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer TM, Santoro A, Lin CC, Garrido-Laguna I, Joerger M, Greil R, Spreafico A, Yau T, Goebeler ME, Hütter-Krönke ML, Perotti A, Juif PE, Lu D, Barys L, Cremasco V, Pelletier M, Evans H, Fabre C, Doi T. Bauer TM, et al. Among authors: doi t. J Immunother Cancer. 2023 Nov 29;11(11):e007353. doi: 10.1136/jitc-2023-007353. J Immunother Cancer. 2023. PMID: 38030303 Free PMC article. Clinical Trial.
Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, non-comparative trial.
Ishiwatari H, Ishikawa K, Sato J, Niiya F, Yasui H, Onozawa Y, Yamazaki K, Todaka A, Tsushima T, Hamauchi S, Yokota T, Kawakami T, Oshima K, Fushiki K, Sakamoto H, Doi T, Yamamura M, Norose T, Ohike N, Notsu A, Ono H. Ishiwatari H, et al. Among authors: doi t. Gastrointest Endosc. 2025 Jun 28:S0016-5107(25)01779-1. doi: 10.1016/j.gie.2025.06.042. Online ahead of print. Gastrointest Endosc. 2025. PMID: 40588041
Birth cohort-specific smoking patterns in Japan (1906-2004): a population-based study from the NC-CCAPH consortium.
Tanaka S, Ihira H, Tajima T, Kanehara R, Inoue Y, Doi T, Kobayashi N, Kato Y, Nishita Y, Konishi M, Nakao YM, Kabe I, Morioka C, Dohi S, Khairan P, Arafa A, Narita ZC, Morisaki N, Lu Y, Otsuka R, Yamaji T, Shimada H, Mizoue T, Sawada N, Tsugane S, Iwasaki M, Inoue M. Tanaka S, et al. Among authors: doi t. Lancet Reg Health West Pac. 2025 May 7;58:101562. doi: 10.1016/j.lanwpc.2025.101562. eCollection 2025 May. Lancet Reg Health West Pac. 2025. PMID: 40475886 Free PMC article.
Clinical effect of three-dimensional left ventricular mechanical dyssynchrony and cardiac sympathetic denervation in systolic heart failure risk-stratified by left ventricular ejection fraction and QRS duration.
Doi T, Morishita K, Furuoka R, Uruno K, Hatano R, Nabuchi M, Masuda K, Komuro K, Iwano H, Nagahara D, Yuda S, Hashimoto A, Nakata T. Doi T, et al. EJNMMI Res. 2025 Jun 2;15(1):64. doi: 10.1186/s13550-025-01257-z. EJNMMI Res. 2025. PMID: 40457139 Free PMC article.
2,687 results